Nascent Biotech Stock Market Value
| NBIO Stock | USD 0.06 0.0002 0.32% |
| Symbol | Nascent |
Nascent Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nascent Biotech's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nascent Biotech.
| 10/30/2024 |
| 11/29/2024 |
If you would invest 0.00 in Nascent Biotech on October 30, 2024 and sell it all today you would earn a total of 0.00 from holding Nascent Biotech or generate 0.0% return on investment in Nascent Biotech over 30 days. Nascent Biotech is related to or competes with Silo Pharma, Protagenic Therapeutics, Sino Biopharmaceutica, and Eledon Pharmaceuticals. Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of v... More
Nascent Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nascent Biotech's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nascent Biotech upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 11.47 | |||
| Information Ratio | 0.0801 | |||
| Maximum Drawdown | 76.58 | |||
| Value At Risk | (15.82) | |||
| Potential Upside | 21.35 |
Nascent Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nascent Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nascent Biotech's standard deviation. In reality, there are many statistical measures that can use Nascent Biotech historical prices to predict the future Nascent Biotech's volatility.| Risk Adjusted Performance | 0.0791 | |||
| Jensen Alpha | 0.9547 | |||
| Total Risk Alpha | (0.69) | |||
| Sortino Ratio | 0.0797 | |||
| Treynor Ratio | 1.58 |
Nascent Biotech Backtested Returns
Nascent Biotech is out of control given 3 months investment horizon. Nascent Biotech has Sharpe Ratio of 0.0953, which conveys that the firm had a 0.0953% return per unit of risk over the last 3 months. We were able to collect and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.1% are justified by taking the suggested risk. Use Nascent Biotech Risk Adjusted Performance of 0.0791, downside deviation of 11.47, and Mean Deviation of 6.85 to evaluate company specific risk that cannot be diversified away. Nascent Biotech holds a performance score of 7 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 0.65, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Nascent Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Nascent Biotech is expected to be smaller as well. Use Nascent Biotech potential upside, as well as the relationship between the kurtosis and day typical price , to analyze future returns on Nascent Biotech.
Auto-correlation | 0.19 |
Very weak predictability
Nascent Biotech has very weak predictability. Overlapping area represents the amount of predictability between Nascent Biotech time series from 30th of October 2024 to 14th of November 2024 and 14th of November 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nascent Biotech price movement. The serial correlation of 0.19 indicates that over 19.0% of current Nascent Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.19 | |
| Spearman Rank Test | 0.1 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Nascent Biotech lagged returns against current returns
Autocorrelation, which is Nascent Biotech otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Nascent Biotech's otc stock expected returns. We can calculate the autocorrelation of Nascent Biotech returns to help us make a trade decision. For example, suppose you find that Nascent Biotech has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Nascent Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Nascent Biotech otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Nascent Biotech otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Nascent Biotech otc stock over time.
Current vs Lagged Prices |
| Timeline |
Nascent Biotech Lagged Returns
When evaluating Nascent Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Nascent Biotech otc stock have on its future price. Nascent Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Nascent Biotech autocorrelation shows the relationship between Nascent Biotech otc stock current value and its past values and can show if there is a momentum factor associated with investing in Nascent Biotech.
Regressed Prices |
| Timeline |
Pair Trading with Nascent Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nascent Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nascent Biotech will appreciate offsetting losses from the drop in the long position's value.Moving against Nascent OTC Stock
| 0.68 | AULT | Ault Alliance Symbol Change | PairCorr |
| 0.65 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.63 | NONOF | Novo Nordisk AS | PairCorr |
| 0.62 | NVO | Novo Nordisk AS | PairCorr |
| 0.6 | QSAM | Qsam Biosciences | PairCorr |
The ability to find closely correlated positions to Nascent Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nascent Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nascent Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nascent Biotech to buy it.
The correlation of Nascent Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nascent Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nascent Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nascent Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Nascent OTC Stock
Nascent Biotech financial ratios help investors to determine whether Nascent OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nascent with respect to the benefits of owning Nascent Biotech security.